Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein
The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternat...
Saved in:
| Published in | PloS one Vol. 6; no. 2; p. e16112 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
18.02.2011
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops.
Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to α(v)β(3) and α(v)β(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α(5)β(1) and α(iib)β(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to α(v)β(3) and α(v)β(5) integrins. A (64)Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys.
We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. |
|---|---|
| AbstractList | The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops.
Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to α(v)β(3) and α(v)β(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α(5)β(1) and α(iib)β(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to α(v)β(3) and α(v)β(5) integrins. A (64)Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys.
We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops.BACKGROUNDThe Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops.Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to α(v)β(3) and α(v)β(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α(5)β(1) and α(iib)β(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to α(v)β(3) and α(v)β(5) integrins. A (64)Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys.METHODOLOGY/PRINCIPAL FINDINGSYeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to α(v)β(3) and α(v)β(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α(5)β(1) and α(iib)β(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to α(v)β(3) and α(v)β(5) integrins. A (64)Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys.We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop.CONCLUSIONS/SIGNIFICANCEWe demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to [alpha].sub.v [beta].sub.3 and [alpha].sub.v [beta].sub.5 integrins with affinities in the low nanomolar range, but bound weakly to the related integrins [alpha].sub.5 [beta].sub.1 and [alpha].sub.iib [beta].sub.3 . In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to [alpha].sub.v [beta].sub.3 and [alpha].sub.v [beta].sub.5 integrins. A .sup.64 Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ~3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. BackgroundThe Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops.Methodology/principal findingsYeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to α(v)β(3) and α(v)β(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α(5)β(1) and α(iib)β(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to α(v)β(3) and α(v)β(5) integrins. A (64)Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys.Conclusions/significanceWe demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. Background The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Methodology/Principal Findings Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to αvβ3 and αvβ5 integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α5β1 and αiibβ3. In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to αvβ3 and αvβ5 integrins. A 64Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3–5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. Conclusions/Significance We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. Background The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Methodology/Principal Findings Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to [alpha].sub.v [beta].sub.3 and [alpha].sub.v [beta].sub.5 integrins with affinities in the low nanomolar range, but bound weakly to the related integrins [alpha].sub.5 [beta].sub.1 and [alpha].sub.iib [beta].sub.3 . In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to [alpha].sub.v [beta].sub.3 and [alpha].sub.v [beta].sub.5 integrins. A .sup.64 Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ~3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. Conclusions/Significance We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. Background The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Methodology/Principal Findings Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to αvβ3 and αvβ5 integrins with affinities in the low nanomolar range, but bound weakly to the related integrins α5β1 and αiibβ3. In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to αvβ3 and αvβ5 integrins. A 64Cu radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was ∼3–5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. Conclusions/Significance We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop. |
| Audience | Academic |
| Author | Cochran, Jennifer R. Jones, Douglas S. Cheng, Zhen Kimura, Richard H. Jiang, Lei Miao, Zheng |
| AuthorAffiliation | 1 Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Cancer Center, Bio-X Program, Stanford University, Stanford, California, United States of America University of Crete, Greece 2 Department of Bioengineering, Cancer Center, Bio-X Program, Stanford University, Stanford, California, United States of America |
| AuthorAffiliation_xml | – name: University of Crete, Greece – name: 2 Department of Bioengineering, Cancer Center, Bio-X Program, Stanford University, Stanford, California, United States of America – name: 1 Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Cancer Center, Bio-X Program, Stanford University, Stanford, California, United States of America |
| Author_xml | – sequence: 1 givenname: Richard H. surname: Kimura fullname: Kimura, Richard H. – sequence: 2 givenname: Douglas S. surname: Jones fullname: Jones, Douglas S. – sequence: 3 givenname: Lei surname: Jiang fullname: Jiang, Lei – sequence: 4 givenname: Zheng surname: Miao fullname: Miao, Zheng – sequence: 5 givenname: Zhen surname: Cheng fullname: Cheng, Zhen – sequence: 6 givenname: Jennifer R. surname: Cochran fullname: Cochran, Jennifer R. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21364742$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11rFDEUhgep2A_9B6IDguLFrskkk-x4IZTS6mJLwVZvQyY5s5uSTcYkU9obf7sZdyvdUkRykcPJc94kL-fsFzvOOyiKlxhNMeH4w5UfgpN22uf0FCHMMK6eFHu4IdWEVYjs3It3i_0YrxCqyYyxZ8VuhQmjnFZ7xa-TwalkfFYqz4Ykx7D0XY5tMr2F8sLba3BpcnzT-wi6PPW-j6VxZVpCeaxaaa0ZViVYmSCM0WW47WM-n7ulaU3yYTKfl0e3MRkH5VfnU3lmnOmDT2Dc8-JpJ22EF5v9oPh-cnx59GVyev55fnR4OlG85mnSYg6NJhiDrLSWiqKOEeAUYWiB4k5pUulOI1whhRiGinBaN03b6W5GKO3IQfF6rdtbH8XGuigwwTPeNIzRTMzXhPbySvTBrGS4FV4a8Sfhw0LIkIyyIGjWRx1CUgGjwNSMtRohpOsWq4pXKmt92tw2tCvQKvsXpN0S3T5xZikW_loQRDGvx8e82wgE_3OAmMTKRAXWSgd-iGJW17iZccIz-eYB-fjnNtRC5vcb1_l8rRo1xSHlrEG0anCmpo9QeWlYGZXbrDM5v1XwfqsgMwlu0kIOMYr5xbf_Z89_bLNv77FLkDYto7fD2JxxG3x13-i_Dt_1dwY-rgEVfIwBOqHMusnz14wVGIlxmO5ME-Mwic0w5WL6oPhO_59lvwHj5yTE |
| CitedBy_id | crossref_primary_10_1002_cmdc_201100497 crossref_primary_10_1107_S0907444912043880 crossref_primary_10_1039_C9MD00252A crossref_primary_10_1371_journal_pone_0300135 crossref_primary_10_1002_psc_2782 crossref_primary_10_1002_ijch_202400010 crossref_primary_10_1016_j_ejps_2022_106339 crossref_primary_10_1146_annurev_anchem_061516_045205 crossref_primary_10_2967_jnumed_115_155176 crossref_primary_10_3389_fimmu_2021_742418 crossref_primary_10_1016_j_abb_2012_03_009 crossref_primary_10_18097_PBMC20166204353 crossref_primary_10_1016_j_nucmedbio_2020_06_007 crossref_primary_10_1021_jacs_6b03765 crossref_primary_10_1093_neuonc_nov169 crossref_primary_10_1016_j_ymeth_2012_03_014 crossref_primary_10_1021_acs_molpharmaceut_2c00313 crossref_primary_10_1371_journal_pone_0299804 crossref_primary_10_1021_acs_jnatprod_8b00716 crossref_primary_10_3390_molecules171112533 crossref_primary_10_1016_j_bmcl_2011_03_110 crossref_primary_10_1021_mp400683q crossref_primary_10_1038_srep35179 crossref_primary_10_1021_acscombsci_0c00076 crossref_primary_10_1038_s41598_019_43285_5 crossref_primary_10_1021_acsbiomedchemau_4c00026 crossref_primary_10_1002_ird3_11 crossref_primary_10_1021_mp500018s crossref_primary_10_1186_s12934_018_0881_3 crossref_primary_10_1021_acs_molpharmaceut_8b01291 crossref_primary_10_1007_s00726_012_1391_y |
| Cites_doi | 10.1371/journal.pcbi.1000499 10.1158/0008-5472.CAN-09-2724 10.1586/erm.10.15 10.1038/nprot.2006.94 10.1016/0092-8674(92)90115-S 10.1158/0008-5472.CAN-10-1338 10.1016/S0022-2836(03)00082-2 10.1002/jmr.1036 10.1016/0955-0674(94)90091-4 10.2967/jnumed.109.069831 10.1074/jbc.M212152200 10.2967/jnumed.107.039859 10.1007/s11912-006-0043-3 10.2174/1389203043379477 10.1007/s00259-006-0136-0 10.1007/s11307-009-0287-z 10.1158/0008-5472.CAN-08-2495 10.1016/S0002-9440(10)65005-5 10.1021/bc9003102 10.2967/jnumed.109.068007 10.1038/sj.gt.3301887 10.1074/jbc.274.30.21037 10.1002/anie.199713741 10.1016/S1074-5521(00)00019-3 10.1021/ar800243b 10.1016/j.jmb.2008.11.004 10.1007/s10555-008-9158-3 10.1158/1535-7163.MCT-09-0195 10.1080/10623320600698037 10.1007/s00259-008-1003-y 10.1111/j.1742-4658.2008.06440.x 10.1093/protein/12.9.797 10.1093/nar/gnh030 10.1002/prot.22441 10.1007/s11307-009-0256-6 10.1016/j.coph.2009.05.004 10.3109/15419069409014213 10.1083/jcb.127.4.1129 10.1021/bc900167c 10.1073/pnas.78.7.4046 10.1080/09537100500436663 10.1016/j.mibio.2004.06.004 10.1021/bi901135x 10.2174/138161208786404308 10.1016/S0070-2153(04)64009-9 10.1021/mp060049x 10.2967/jnumed.107.047381 10.1021/bc0300403 10.1021/bc800455p 10.1016/S0041-0101(00)00160-4 10.1111/j.1399-3011.1989.tb00210.x 10.1021/bc900361g 10.1002/pro.5560031022 10.1146/annurev.cellbio.12.1.697 10.1111/j.1742-4658.2006.05567.x 10.1186/1472-6807-8-54 10.1126/science.7512751 10.1021/bc0501698 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2011 Public Library of Science 2011 Kimura et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Kimura et al. 2011 |
| Copyright_xml | – notice: COPYRIGHT 2011 Public Library of Science – notice: 2011 Kimura et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Kimura et al. 2011 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0016112 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints in Context Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Engineering Biology |
| DocumentTitleAlternate | Engineering Multiple Loops in EETI-II |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1318799664 oai_doaj_org_article_4e230f00ace64e6c86bd000d5b1c272c PMC3041754 2921676191 A476904291 21364742 10_1371_journal_pone_0016112 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States--US California |
| GeographicLocations_xml | – name: United States--US – name: California |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R25 CA118681 – fundername: NCI NIH HHS grantid: P50 CA114747 – fundername: NCI NIH HHS grantid: 5R01 CA119053 – fundername: NCI NIH HHS grantid: R01 CA119053 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. BBORY CGR CUY CVF ECM EIF NPM PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c757t-b17e9d311ea2ddac40f63e7401ebe41fcd32dfd0120c061e2374599bfdf8344f3 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Fri Nov 26 17:12:51 EST 2021 Wed Aug 27 00:37:52 EDT 2025 Thu Aug 21 14:05:36 EDT 2025 Fri Jul 11 08:17:46 EDT 2025 Fri Jul 25 11:55:39 EDT 2025 Tue Jun 17 20:57:10 EDT 2025 Tue Jun 10 20:27:27 EDT 2025 Fri Jun 27 04:03:30 EDT 2025 Fri Jun 27 03:55:13 EDT 2025 Thu May 22 21:20:34 EDT 2025 Wed Feb 19 02:30:56 EST 2025 Tue Jul 01 02:28:55 EDT 2025 Thu Apr 24 23:05:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c757t-b17e9d311ea2ddac40f63e7401ebe41fcd32dfd0120c061e2374599bfdf8344f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: RHK DSJ ZC JRC. Performed the experiments: RHK DSJ LJ ZM. Analyzed the data: RHK DSJ LJ ZC. Wrote the paper: RHK DSJ JRC. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0016112 |
| PMID | 21364742 |
| PQID | 1318799664 |
| PQPubID | 1436336 |
| PageCount | e16112 |
| ParticipantIDs | plos_journals_1318799664 doaj_primary_oai_doaj_org_article_4e230f00ace64e6c86bd000d5b1c272c pubmedcentral_primary_oai_pubmedcentral_nih_gov_3041754 proquest_miscellaneous_855198737 proquest_journals_1318799664 gale_infotracmisc_A476904291 gale_infotracacademiconefile_A476904291 gale_incontextgauss_ISR_A476904291 gale_incontextgauss_IOV_A476904291 gale_healthsolutions_A476904291 pubmed_primary_21364742 crossref_citationtrail_10_1371_journal_pone_0016112 crossref_primary_10_1371_journal_pone_0016112 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-02-18 |
| PublicationDateYYYYMMDD | 2011-02-18 |
| PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-18 day: 18 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2011 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | S Kim (ref21) 2000; 156 E Ruoslahti (ref25) 1996; 12 CH Nielsen (ref38) 2010; 70 AJ Beer (ref42) 2008; 27 A Wentzel (ref31) 1999; 274 RH Kimura (ref8) 2009; 77 Z Cheng (ref41) 2010; 12 G Chao (ref59) 2006; 1 AP Silverman (ref12) 2009; 385 H Kolmar (ref3) 2009; 9 DJ Craik (ref4) 2001; 39 A Heitz (ref13) 2008; 8 JR Cochran (ref48) 2000; 7 H Kolmar (ref36) 2010; 10 Z Miao (ref34) 2010; 12 W Cai (ref62) 2005; 39 AP Silverman (ref11) 2011; 24 ZB Li (ref46) 2007; 48 C Zahnd (ref54) 2010; 70 S Liu (ref44) 2006; 3 Y Wu (ref53) 2005; 46 PC Brooks (ref20) 1994; 264 R Garcia Boy (ref37) 2010; 12 GC Tucker (ref30) 2006; 8 S Liu (ref45) 2009; 20 A Christmann (ref6) 1999; 12 JS Swers (ref58) 2004; 32 Z Miao (ref22) 2009; 20 J Richards (ref61) 2003; 326 RH Kimura (ref33) 2010; 21 MM Schmidt (ref55) 2009; 8 W Cai (ref16) 2008; 14 L Jiang (ref32) 2010; 51 J Shi (ref52) 2009; 20 L Chiche (ref2) 2004; 5 RH Kimura (ref23) 2009; 69 TA Haas (ref40) 1994; 6 JK Willmann (ref35) 2010; 51 PK Pallaghy (ref1) 1994; 3 GC Alghisi (ref18) 2006; 13 RO Hynes (ref15) 1992; 69 SD Blystone (ref29) 1994; 127 S Reiss (ref10) 2006; 17 X Zhang (ref26) 2006; 47 JL Lahti (ref24) 2009; 5 X Chen (ref49) 2004; 15 V Tolmachev (ref57) 2009; 36 Z Cheng (ref60) 2005; 16 R Haubner (ref17) 2006; 33 X Chen (ref50) 2004; 6 Z Cheng (ref56) 2008; 49 A Favel (ref14) 1989; 33 S Krause (ref9) 2007; 274 WP Jencks (ref47) 1981; 78 M Schottelius (ref43) 2009; 42 H Kolmar (ref5) 2008; 275 M Pfaff (ref27) 1994; 2 R Haubner (ref39) 1997; 36 S Lee (ref51) 2010; 49 K Hilpert (ref7) 2003; 278 A Bruning (ref28) 2003; 10 DG Stupack (ref19) 2004; 64 |
| References_xml | – volume: 5 start-page: e1000499 year: 2009 ident: ref24 article-title: Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein. publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1000499 – volume: 70 start-page: 1595 year: 2010 ident: ref54 article-title: Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2724 – volume: 10 start-page: 361 year: 2010 ident: ref36 article-title: Engineered cystine-knot miniproteins for diagnostic applications. publication-title: Expert Rev Mol Diagn doi: 10.1586/erm.10.15 – volume: 1 start-page: 755 year: 2006 ident: ref59 article-title: Isolating and engineering human antibodies using yeast surface display. publication-title: Nat Protoc doi: 10.1038/nprot.2006.94 – volume: 69 start-page: 11 year: 1992 ident: ref15 article-title: Integrins: versatility, modulation, and signaling in cell adhesion. publication-title: Cell doi: 10.1016/0092-8674(92)90115-S – volume: 70 start-page: 9022 year: 2010 ident: ref38 article-title: PET Imaging of Tumor Neovascularization in a Transgenic Mouse Model with a Novel 64Cu-DOTA-Knottin Peptide. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-1338 – volume: 326 start-page: 1475 year: 2003 ident: ref61 article-title: Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human αvβ3 integrin. publication-title: J Mol Biol doi: 10.1016/S0022-2836(03)00082-2 – volume: 24 start-page: 127 year: 2011 ident: ref11 article-title: Cystine-knot peptides engineered with specificities for αiibβ3 or αiibβ3 and αvβ3 integrins are potent inhibitors of platelet aggregation. publication-title: J Mol Recognit doi: 10.1002/jmr.1036 – volume: 6 start-page: 656 year: 1994 ident: ref40 article-title: Integrin-ligand interactions: a year in review. publication-title: Curr Opin Cell Biol doi: 10.1016/0955-0674(94)90091-4 – volume: 51 start-page: 251 year: 2010 ident: ref32 article-title: Evaluation of a 64Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing αvβ3 integrin. publication-title: J Nucl Med doi: 10.2967/jnumed.109.069831 – volume: 278 start-page: 24986 year: 2003 ident: ref7 article-title: Design and characterization of a hybrid miniprotein that specifically inhibits porcine pancreatic elastase. publication-title: J Biol Chem doi: 10.1074/jbc.M212152200 – volume: 48 start-page: 1162 year: 2007 ident: ref46 article-title: 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor αvβ3 integrin expression. publication-title: J Nucl Med doi: 10.2967/jnumed.107.039859 – volume: 8 start-page: 96 year: 2006 ident: ref30 article-title: Integrins: molecular targets in cancer therapy. publication-title: Curr Oncol Rep doi: 10.1007/s11912-006-0043-3 – volume: 46 start-page: 1707 year: 2005 ident: ref53 article-title: microPET imaging of glioma integrin αvβ3 expression using 64Cu-labeled tetrameric RGD peptide. publication-title: J Nucl Med – volume: 5 start-page: 341 year: 2004 ident: ref2 article-title: Squash inhibitors: from structural motifs to macrocyclic knottins. publication-title: Curr Protein Pept Sci doi: 10.2174/1389203043379477 – volume: 33 start-page: 54 year: 2006 ident: ref17 article-title: αvβ3-integrin imaging: a new approach to characterise angiogenesis? publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-006-0136-0 – volume: 12 start-page: 377 year: 2010 ident: ref37 article-title: Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals. publication-title: Mol Imaging Biol doi: 10.1007/s11307-009-0287-z – volume: 69 start-page: 2435 year: 2009 ident: ref23 article-title: Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2495 – volume: 156 start-page: 1345 year: 2000 ident: ref21 article-title: Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)65005-5 – volume: 21 start-page: 436 year: 2010 ident: ref33 article-title: A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. publication-title: Bioconjug Chem doi: 10.1021/bc9003102 – volume: 51 start-page: 433 year: 2010 ident: ref35 article-title: Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. publication-title: J Nucl Med doi: 10.2967/jnumed.109.068007 – volume: 10 start-page: 198 year: 2003 ident: ref28 article-title: CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. publication-title: Gene Ther doi: 10.1038/sj.gt.3301887 – volume: 274 start-page: 21037 year: 1999 ident: ref31 article-title: Sequence requirements of the GPNG beta-turn of the Ecballium elaterium trypsin inhibitor II explored by combinatorial library screening. publication-title: J Biol Chem doi: 10.1074/jbc.274.30.21037 – volume: 36 start-page: 1374 year: 1997 ident: ref39 article-title: Stereoisomeric peptide libaries and peptidomimetics for designing selective inhibitors of the αvβ3 integrin for a new cancer therapy. publication-title: Angew Chem Int Ed doi: 10.1002/anie.199713741 – volume: 7 start-page: 683 year: 2000 ident: ref48 article-title: A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. publication-title: Chem Biol doi: 10.1016/S1074-5521(00)00019-3 – volume: 42 start-page: 969 year: 2009 ident: ref43 article-title: Ligands for mapping αvβ3-integrin expression in vivo. publication-title: Acc Chem Res doi: 10.1021/ar800243b – volume: 385 start-page: 1064 year: 2009 ident: ref12 article-title: Engineered cystine-knot peptides that bind αvβ3 integrin with antibody-like affinities. publication-title: J Mol Biol doi: 10.1016/j.jmb.2008.11.004 – volume: 27 start-page: 631 year: 2008 ident: ref42 article-title: Imaging of integrin αvβ3 expression. publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9158-3 – volume: 8 start-page: 2861 year: 2009 ident: ref55 article-title: A modeling analysis of the effects of molecular size and binding affinity on tumor targeting. publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-09-0195 – volume: 13 start-page: 113 year: 2006 ident: ref18 article-title: Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. publication-title: Endothelium doi: 10.1080/10623320600698037 – volume: 36 start-page: 692 year: 2009 ident: ref57 article-title: Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules. publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-008-1003-y – volume: 275 start-page: 2684 year: 2008 ident: ref5 article-title: Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins. publication-title: FEBS J doi: 10.1111/j.1742-4658.2008.06440.x – volume: 12 start-page: 797 year: 1999 ident: ref6 article-title: The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides. publication-title: Protein Eng doi: 10.1093/protein/12.9.797 – volume: 32 start-page: e36 year: 2004 ident: ref58 article-title: Shuffled antibody libraries created by in vivo homologous recombination and yeast surface display. publication-title: Nucleic Acids Res doi: 10.1093/nar/gnh030 – volume: 77 start-page: 359 year: 2009 ident: ref8 article-title: Engineered cystine knot peptides that bind αvβ3, αvβ5, and α5β1 integrins with low-nanomolar affinity. publication-title: Proteins doi: 10.1002/prot.22441 – volume: 12 start-page: 316 year: 2010 ident: ref41 article-title: 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. publication-title: Mol Imaging Biol doi: 10.1007/s11307-009-0256-6 – volume: 9 start-page: 608 year: 2009 ident: ref3 article-title: Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2009.05.004 – volume: 2 start-page: 491 year: 1994 ident: ref27 article-title: Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins αiibβ3, αvβ3 and α5β1 and in cell adhesion inhibition. publication-title: Cell Adhes Commun doi: 10.3109/15419069409014213 – volume: 12 year: 2010 ident: ref34 article-title: Protein scaffold-based molecular probes for cancer molecular imaging. publication-title: Amino Acids epub Feb – volume: 127 start-page: 1129 year: 1994 ident: ref29 article-title: Integrin αvβ3 differentally regulates adhesive and phagocytic functions of the fibronectin receptor α5β1. publication-title: J Cell Biol doi: 10.1083/jcb.127.4.1129 – volume: 20 start-page: 2199 year: 2009 ident: ref45 article-title: Radiolabeled cyclic RGD peptides as integrin αvβ3-targeted radiotracers: maximizing binding affinity via bivalency. publication-title: Bioconjug Chem doi: 10.1021/bc900167c – volume: 78 start-page: 4046 year: 1981 ident: ref47 article-title: On the attribution and additivity of binding energies. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.78.7.4046 – volume: 17 start-page: 153 year: 2006 ident: ref10 article-title: Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. publication-title: Platelets doi: 10.1080/09537100500436663 – volume: 6 start-page: 350 year: 2004 ident: ref50 article-title: MicroPET imaging of breast cancer αv-integrin expression with 64Cu-labeled dimeric RGD peptides. publication-title: Mol Imaging Biol doi: 10.1016/j.mibio.2004.06.004 – volume: 49 start-page: 1364 year: 2010 ident: ref51 article-title: Peptide-based probes for targeted molecular imaging. publication-title: Biochemistry doi: 10.1021/bi901135x – volume: 14 start-page: 2943 year: 2008 ident: ref16 article-title: Imaging of integrins as biomarkers for tumor angiogenesis. publication-title: Curr Pharm Des doi: 10.2174/138161208786404308 – volume: 64 start-page: 207 year: 2004 ident: ref19 article-title: Integrins and angiogenesis. publication-title: Curr Top Dev Biol doi: 10.1016/S0070-2153(04)64009-9 – volume: 47 start-page: 113 year: 2006 ident: ref26 article-title: Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2. publication-title: J Nucl Med – volume: 3 start-page: 472 year: 2006 ident: ref44 article-title: Radiolabeled multimeric cyclic RGD peptides as integrin αvβ3 targeted radiotracers for tumor imaging. publication-title: Mol Pharm doi: 10.1021/mp060049x – volume: 49 start-page: 804 year: 2008 ident: ref56 article-title: Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. publication-title: J Nucl Med doi: 10.2967/jnumed.107.047381 – volume: 15 start-page: 41 year: 2004 ident: ref49 article-title: MicroPET and autoradiographic imaging of breast cancer αv-integrin expression using 18F- and 64Cu-labeled RGD peptide. publication-title: Bioconjug Chem doi: 10.1021/bc0300403 – volume: 20 start-page: 750 year: 2009 ident: ref52 article-title: Improving tumor uptake and pharmacokinetics of 64Cu-labeled cyclic RGD peptide dimers with Gly3 and PEG4 linkers. publication-title: Bioconjug Chem doi: 10.1021/bc800455p – volume: 39 start-page: 43 year: 2001 ident: ref4 article-title: The cystine knot motif in toxins and implications for drug design. publication-title: Toxicon doi: 10.1016/S0041-0101(00)00160-4 – volume: 39 start-page: S6 year: 2005 ident: ref62 article-title: Multimodality tumor imaging targeting integrin αvβ3. publication-title: Biotechniques – volume: 33 start-page: 202 year: 1989 ident: ref14 article-title: Protease inhibitors from Ecballium elaterium seeds. publication-title: Int J Pept Protein Res doi: 10.1111/j.1399-3011.1989.tb00210.x – volume: 20 start-page: 2342 year: 2009 ident: ref22 article-title: An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. publication-title: Bioconjug Chem doi: 10.1021/bc900361g – volume: 3 start-page: 1833 year: 1994 ident: ref1 article-title: A common structural motif incorporating a cystine knot and a triple-stranded beta-sheet in toxic and inhibitory polypeptides. publication-title: Protein Sci doi: 10.1002/pro.5560031022 – volume: 12 start-page: 697 year: 1996 ident: ref25 article-title: RGD and other recognition sequences for integrins. publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev.cellbio.12.1.697 – volume: 274 start-page: 86 year: 2007 ident: ref9 article-title: Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists. publication-title: FEBS J doi: 10.1111/j.1742-4658.2006.05567.x – volume: 8 start-page: 54 year: 2008 ident: ref13 article-title: Knottin cyclization: impact on structure and dynamics. publication-title: BMC Struct Biol doi: 10.1186/1472-6807-8-54 – volume: 264 start-page: 569 year: 1994 ident: ref20 article-title: Requirement of vascular integrin αvβ3 for angiogenesis. publication-title: Science doi: 10.1126/science.7512751 – volume: 16 start-page: 1433 year: 2005 ident: ref60 article-title: Near-infrared fluorescent RGD peptides for optical imaging of integrin αvβ3 expression in living mice. publication-title: Bioconjug Chem doi: 10.1021/bc0501698 |
| SSID | ssj0053866 |
| Score | 2.2042277 |
| Snippet | The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that... Background The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide... BackgroundThe Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide... Background The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e16112 |
| SubjectTerms | Adhesive bonding Amino Acid Sequence Amino acids Animals Antigenic determinants Binding Bioengineering Biology Cancer Cell adhesion Cell Adhesion - drug effects Chemical bonds Cucurbitaceae - chemistry Cysteine Cystine Cystine Knot Motifs - genetics Cystine Knot Motifs - physiology Disulfide bonds Dosage Ecballium elaterium Engineering Epidermal growth factor Epitopes Extracellular matrix Female Genetic aspects Humans Integrins K562 Cells Kidneys Libraries Matrix protein Medical screening Mice Mice, Nude Models, Molecular Molecular Sequence Data Mutagenesis, Site-Directed Mutation Mutation - physiology Peptide Fragments - chemical synthesis Peptide Fragments - chemistry Peptide Fragments - genetics Peptide Fragments - pharmacology Peptides Positron emission Positron emission tomography Protein Binding Protein Engineering - methods Protein Folding - drug effects Protein Structure, Tertiary - genetics Proteins Receptors Sequence Homology, Amino Acid Solvents Solvents - pharmacology Stability Trypsin Trypsin inhibitors Trypsin Inhibitors - chemistry Trypsin Inhibitors - genetics Trypsin Inhibitors - isolation & purification Trypsin Inhibitors - metabolism Tumor Cells, Cultured Tumors Vitronectin Xenograft Model Antitumor Assays Xenografts Yeast |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnLggyquBACuEBBy29dobr30sqFGDBEhAUW_Weh-tRbq24kSiF347M17HqlGlcuAWeSdW8s3szKw98w0hr61xaSryjM0hWDCR5ZwplTmmJAQrSJDzXGK_86fP6cmp-Hg2P7s26gtrwgI9cADuUFhIkl0UKW1TYVOdpaWBbWzmJdexjDV6X4h5u8NU8MGwi9O0b5RLJD_s9XLQ1N4edFkOj0eBqOPrH7zypFnV7U0p59-Vk9dC0eI-udfnkPQo_PY9csf6B2Sv36UtfdtTSb97SH4vIGyFp330chveutPa0V0ZIQXLw4JHZn81dWsNXdV109LKU8gL6bEu1WpVbS8pVsyBqcKnzfqqaWG98hdVCd5gzZZLqq_AUXhLf_p6Q5GspGN_qPwjcro4_v7hhPUTF5iWc7lhJZc2NwnnVsXGKC0ilyYWh_aBrgV32iSxcQYbbjXoFlQjxTzPS2cczutwyWMy8YDxPqFaIdM8t1nkShGVKlepM9IIpaTGM9qUJDv4C93TkeNUjFXRvWOTcCwJaBaotKJX2pSw4VtNoOO4Rf49anaQRTLt7gKYWNGbWHGbiU3JS7SLInSmDi6hOBIyzTGg8yl51UkgoYbHip1ztW3bYvnlxz8Iffs6EnrTC7ka4NCq75KA_4REXSPJ2UgS3IIeLe-jFe9QaQEjHCwPp1uAfraz7JuX6bCMN8UqPG_rbVtkkF7nmUzklDwJ-2AANuY4iEAA4HK0Q0bIj1d8ddHRmSeRgBxWPP0fqnpG7oaH_jHj2YxMNuutfQ5Z46Z80TmIP6nXbnY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF5BuMChouXRQIEVQgIO23rtjdc-oVI1NEBAoi3qzVrvo7UUbBMnEr3w25mxN6FGFXCLMuPEntl5eHfmG0JeWOPiWKQJG0GwYCJJOVMqcUxJCFaQIKepxH7n6af46FS8Pxud-Q23xpdVrnxi66hNpXGPfI9HOBcbknPxpv7OcGoUnq76ERo3yS0OkQZLupLxu5UnBluOY98uF0m-57WzW1el3W1zHR72wlGL2r_2zYN6VjXXJZ5_1k9eCUjju2TDZ5J0v1P9Jrlhyy1y5wq-4BbZ9Jbb0FceXvr1PfJzDKGs2wGk02V3Ek8rR6e-tJAeVzMsgmSHP-qqsYZ-rKq6oUVJIVekhzpXs1mx_Eaxig7-Bz6dzC_rBuiT8qLIwUPM2WRCDy7BeZSWfiirBZ0WZdEiQhTlfXI6Pjw5OGJ-CgPTciQXLOfSpibi3KrQGKVF4OLI4iA_0L_gTpsoNM5gE64GfdswkmKUprkzDmd4uOgBGZQg8W1CtUL0eW6TwOUiyFWqYmekEUpJje9tQxKtlJFpD1GOkzJmWXvuJuFVpZNthirMvAqHhK2vqjuIjn_wv0U9r3kRYLv9opqfZ95eMwHPEbggUNrGwsY6iXMD0cOMcq5DGeoheYarJOu6VdduItsXMk4xyPMhed5yIMhGiVU852rZNNnk89f_YDr-0mN66ZlcBeLQyndOwDMheFePc6fHCa5C98jbuKZXUmmy30YFV67W-fVkuibjj2JlXmmrZZMlkHKniYzkkDzsrGIt2JDjcAIBApc9e-lJvk8pi4sW4jwKBOS14tHf7-oxud1t8YeMJztksJgv7RPIERf509YR_AIt42kX priority: 102 providerName: ProQuest |
| Title | Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21364742 https://www.proquest.com/docview/1318799664 https://www.proquest.com/docview/855198737 https://pubmed.ncbi.nlm.nih.gov/PMC3041754 https://doaj.org/article/4e230f00ace64e6c86bd000d5b1c272c http://dx.doi.org/10.1371/journal.pone.0016112 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VVEhwQLQ8GghhhZCAgyM_Nl77gFAbJTRACupLuVnrfbSWgh3iRGou_HZmbMeqURCIixV5Zh15dl7rnf2GkNdaGd9nYWD1IVhYLAgdS4jAWIJDsIIEOQw5nneenPjHF-zTtD_dIZuerZUA861LO-wndbGY9W5-rD-Awb8vujZwZzOoN89S3StyGGw7vAuxiWNPgwmr9xXAun2_OkD3p5EFPDCiqjO3EasKSP_acbfmsyzflpX-Xlx5K1qNHpIHVZpJD0u92CM7Ot0nd8vGk-t9cv8WDOE-2asMPKdvKxTqd4_IzxFEvPJDIZ2syg17mhk6qSoQ6Vk2w1pJa3gzz3Kt6Jcsm-c0SSmklHQoYzGbJavvFIvt4H_g1_liPc-BPk6vkxgcycIaj-lgDT4m1fRzmi3pJEmTAjgiSR-Ti9HwfHBsVc0aLMn7fGnFDteh8hxHC1cpIZltfE9jvz9QE-YYqTxXGYVndSWohXY9zvphGBtlsNWH8Z6QVgrTcECoFAhS7-jANjGzYxEK3yiumBBc4vKuTbzNtESyQjLHhhqzqNie47CiKaUc4bxG1by2iVWPmpdIHn_hP8IZr3kRh7u4kS2uosqsIwbvYRvbFlL7TPsy8GMFQUb1Y0e63JVt8hL1JSoPtdbeJDpk3A8xF3Da5FXBgVgcKRb7XIlVnkfjr5f_wHR22mB6UzGZDMQhRXXAAt4JMb4anJ0GJ3gU2SAfoHZvpJKDjLAnPSyMQfSdjcZvJ9OajA_FAr5UZ6s8CiAzDwPu8TZ5WtpHLdiNtbUJb1hOQ_JNSppcF0jong023mfP_nvkc3Kv3CRwLSfokNZysdIvIMtcxl1yh085XIOBg9fRxy7ZPRqefDvtFt9tuoVj-QXdWIQk |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOQAHRMujC4VaCAQc0saJN04OCJXSpUu7RaIP9RYcP9pISxI2u4Je-En8RmbyWBpUAZfeVvEkG8-MvxnH8yDkmdE2CHgUOn0wFg4PI-ZIGVpHCjBW4CBHkcB859F-sHPEP5z0TxbIzzYXBsMqW0ysgFrnCr-RbzAf-2KDc87fFF8d7BqFp6ttC41aLXbN-TfYspWvh-9Avs89b7B9uLXjNF0FHCX6YuokTJhI-4wZ6WktFXdt4BtsTAfz4cwq7XvaakwqVfD-xvMF70dRYrXFnhTWh-deI9e5D5YcM9MH71vkB-wIgiY9zxdso9GG9SLPzHrlWzGvY_6qLgFzW7BYjPPyMkf3z3jNCwZwcIfcbjxXulmr2hJZMNkyuXWhnuEyWWqQoqQvm3LWr-6SHwMwnfUXRzqa1Sf_NLd01IQy0oN8jEGXzvb3Ii-Npnt5XpQ0zSj4pnRbJXI8TmdfKEbtwf_Ar8PJeVHC-DA7SxNApIkzHNKtcwCrzNDdLJ_SUZqlVQWKNLtHjq5EPvfJYgYcXyFUSax2z0zo2oS7iYxkYLXQXEqhcJ_YI34rjFg1JdGxM8c4rs75BGyNat7GKMK4EWGPOPO7irokyD_o36Kc57RY0Lu6kE9O4wYfYg7zcK3rSmUCbgIVBokGa6X7CVOe8FSPrKGWxHV27ByW4k0uggidCtYjTysKLOqRYdTQqZyVZTz8ePwfRAefOkQvGiKbAzuUbDI1YE5YLKxDudqhBGhSneEV1OmWK2X8exHDna2eXz5M58P4UIwEzEw-K-MQXPwoFL7okQf1qpgz1mPYDIEDw0VnvXQ43x3J0rOqpLrvcvCj-cO_v9UaubFzONqL94b7u4_Izfp4wXNYuEoWp5OZeQz-6TR5UoECJZ-vGoV-AaNzpsM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIiE4IFoeDRS6QiDg4NZrb7z2AaHSNmpoUxBtUW9mvY_WUrBNnAh64Yfx65ixHVOjCrj0FmXHTnYe38za8yDkmdE2CHgUOn1wFg4PI-ZIGVpHCnBWECBHkcB659FBsHvM3530TxbIz3ktDKZVzjGxAmqdK3xGvsF8nIsNwTnfsE1axIftwZviq4MTpPBN63ycRq0ie-b8GxzfytfDbZD1c88b7Bxt7TrNhAFHib6YOgkTJtI-Y0Z6WkvFXRv4BofUwd44s0r7nrYaC0wV7MV4vuD9KEqstjifwvpw32vkuvBFiDYWbrXpJYAjQdCU6vmCbTSasV7kmVmv4izmdVxhNTGg9QuLxTgvLwt6_8zdvOAMB3fI7SaKpZu12i2RBZMtk1sXehsuk6UGNUr6smlt_eou-TEAN1o_faSjWZ0FQHNLR01aIz3Mx5iA6ex8L_LSaLqf50VJ04xCnEp3VCLH43T2hWIGH_wOfDqanBclrA-zszQBdJo4wyHdOgfgygzdy_IpHaVZWnWjSLN75PhK5HOfLGbA8RVClcTO98yErk24m8hIBlYLzaUUCs-MPeLPhRGrpj06TukYx9U7PwHHpJq3MYowbkTYI057VVG3B_kH_VuUc0uLzb2rL_LJadxgRcxhH651XalMwE2gwiDR4Ll0P2HKE57qkTXUkriulG0hKt7kIogwwGA98rSiwAYfGZrKqZyVZTx8_-k_iA4_doheNEQ2B3Yo2VRtwJ6wcViHcrVDCTClOssrqNNzrpTxb4OGK-d6fvkybZfxppgVmJl8VsYhhPtRCNbXIw9qq2gZ6zEcjMCB4aJjLx3Od1ey9Kxqr-67HGJq_vDv_2qN3AD8ifeHB3uPyM36TYPnsHCVLE4nM_MYQtVp8qTCBEo-XzUI_QLLZqrE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+Mutation+of+Multiple+Solvent-Exposed+Loops+in+the+Ecballium+elaterium+Trypsin+Inhibitor-II+Cystine+Knot+Miniprotein&rft.jtitle=PloS+one&rft.au=Kimura%2C+Richard+H.&rft.au=Jones%2C+Douglas+S.&rft.au=Jiang%2C+Lei&rft.au=Miao%2C+Zheng&rft.date=2011-02-18&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=6&rft.issue=2&rft_id=info:doi/10.1371%2Fjournal.pone.0016112&rft_id=info%3Apmid%2F21364742&rft.externalDocID=PMC3041754 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |